UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038879
Receipt number R000043007
Scientific Title Efficacy of closed loop stimulation pacing in patients with heart failure
Date of disclosure of the study information 2020/01/01
Last modified on 2019/12/13 16:22:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of closed loop stimulation pacing in patients with heart failure

Acronym

closed loop simulation pacing-heart failure

Scientific Title

Efficacy of closed loop stimulation pacing in patients with heart failure

Scientific Title:Acronym

closed loop simulation pacing-heart failure

Region

Japan


Condition

Condition

chronic heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of closed loop stimulation for rate adaption in patients with advanced heart failure with cardiac resynchronization therapy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1. The differences in NT-proBNP
2. The differences in Minnesota Living With Heart Failure Questionnaire

Key secondary outcomes

The differences in the following parameters during 6 months of closed loop stimulation
1.6-minute walking distance
2.variation in heart rate
3.New York Heart Association classification
4.cardiothoracic ratio
5.parameters in echocardiography
6.rehospitalization rate for acute exacerbation of heart failure, time to rehospitalization, all cause death, all cause rehospitalizatoin
7.kidney function including serum creatinine, eGFR, BUN
8.incidence of atrial fibrillation and its burden
9.percentage of atrial and ventricular pacing


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Activate closed loop stimulation

Interventions/Control_2

Deactivate closed loop stimulation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Diagnosed with heart failure according to the ESC 2016 guidelines for the diagnosis and treatment of acute and chronic heart failure
CRT-p or CRT-D is needed according to the JCS guidelines for the diagnosis and treatment of acute and chronic heart failure; patients who meet all the following criteria: Receiving optimal medical therapy, NYHA III/IV, sinus rhythm, LVEF(Left ventricular ejection fraction) less than 35%, Left bundle branch block (LBBB) with QRS interval greter than 130 msec
Patients who has already implanted with CTT-P/CRT-D and also CLS is inactivated: patients who meet all the following criteria: NYHA II/III/IV, LBBB was documented at device was implated, medication was not changed last 3 months prior to enrollment
Age 20 years or more
Mental inability to perticipate

Key exclusion criteria

Used at enrollment or planned during study mechanical circulatory suppoft, including intraaortic balloon pumping, percutaneous cardiopulmonary suport, continuous hemodiafiltration, left ventricular assist device
Acute coronary syndrome
Planned cardiac surgery for heart failure
Chronic kidney disease(Creatinene 2.5mg/dl or more) and maintenance dialysis
Malignancy
Pregnancy or possible pregnancy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Ishihara
Middle name
Last name Shiro

Organization

Nippon Medical School Musashi-Kosugi Hospital

Division name

Department of Cardiology

Zip code

211-8533

Address

1-396 Kosugi-cho, Nakahra-ku, Kawasaki 211-8533, Japan

TEL

044-733-5181

Email

s-ishihara@nms.ac.jp


Public contact

Name of contact person

1st name Ishihara
Middle name
Last name Shiro

Organization

Nippon Medical School Musashi-Kosugi Hospital

Division name

Department of Cardiology

Zip code

211-8533

Address

1-396 Kosugi-cho, Nakahra-ku, Kawasaki 211-8533, Japan

TEL

044-733-5181

Homepage URL


Email

s-ishihara@nms.ac.jp


Sponsor or person

Institute

Nippon Medical School Musashi-Kosugi Hospital

Institute

Department

Personal name



Funding Source

Organization

Nippon Medical School Musashi-Kosugi Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nippon Medical School Musashi-Kosugi Hospital

Address

1-396 Kosugi-cho, Nakahra-ku, Kawasaki 211-8533, Japan

Tel

044-733-5181

Email

s-ishihara@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 01 Month 01 Day

Date of IRB

2018 Year 01 Month 01 Day

Anticipated trial start date

2018 Year 02 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 12 Month 13 Day

Last modified on

2019 Year 12 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043007


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name